Clinical trial Recruiting at 1 site Interventional Ages 19 and up

Comparing intrathecal morphine and continuous wound infiltration for pain relief after pancreatic surgery

Official title: Effect of Single-Shot Intrathecal Morphine Injection Versus Continuous Wound Infiltration on Postoperative Pain After Pancreaticoduodenectomy: a Prospective, Open-Label, Randomized Controlled, Non-Inferiority Trial

Run by Seoul National University Hospital · NCT06761989 · Data updated 2026-11-12

This study is testing whether a single injection of morphine into the spine can help manage pain better than a continuous pain relief method after pancreatic surgery for adults.

Quick facts

Study typeInterventional
Ages19 Years and up
SexAll
Enrollment104 (estimated)
SponsorSeoul National University Hospital
Academic / other
Locations1 site (Seoul, Seoul)
StatusRecruiting
StartedJanuary 15, 2025
Main results expectedDecember 31, 2026
Study endsJanuary 7, 2027
Registry record updatedMarch 19, 2025
Trial IDNCT06761989 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 19 and older scheduled for elective open pancreaticoduodenectomy with a performance status of 0 or 1.

Probably not a fit

Patients with hypersensitivity to pain control medications or those with cognitive impairments affecting their ability to use pain management devices may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial is a prospective randomized open-label noninferiority comparison of intrathecal morphine injection versus continuous wound infiltration for pain management following open pancreaticoduodenectomy. The study aims to evaluate the effectiveness of these two analgesic methods, particularly focusing on their ability to manage severe postoperative pain resulting from the surgical procedure. Intrathecal morphine is hypothesized to provide potent, long-lasting pain relief with a single injection, while continuous wound infiltration requires catheter placement and may not effectively address visceral pain. The trial will enroll adults scheduled for elective pancreatic surgery and assess their pain management outcomes postoperatively.

Why it matters

Potential benefit: If successful, this study could provide a more effective and convenient pain management option for patients undergoing pancreatic surgery.

How similar studies have gone: Previous studies have shown that intrathecal morphine can provide effective analgesia, but this specific comparison with continuous wound infiltration has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults 19 years of age or older
* Scheduled for elective open pancreaticoduodenectomy or pylorus preseriving pancreaticoduodenectomy
* Disease of periampullary lesions
* Perfromance status assessed with ECOG score is 0 or 1 at the time of enrollment
* Able to provide written informed consent to participate in the study, understand the procedures of this study, and complete patient-reported questionnaires
* American Society of Anesthesiologists physical status I to III

Exclusion Criteria:

* Hypersensitivity to medications used for pain control (fentanyl, ropivacaine, morphine, acetaminophen, NSAIDs)
* Cognitive impairment that affects using patient-controlled analgesia device or answering patient-reported questionnaires
* Infection or anatomical abnormalities of the abdominal wall and skin that preclude catheterization for continuous wound infiltration
* Contraindicated for intrathecal injection due to any coagulation disorder or continued use of anticoagulants
* Have a major medical or psychiatric illness that would affect response to treatment
* History of chronic pain, or chronic use of analgesics or psychiatric medications
* Have severe liver or kidney disease
* Anyone who are not appropriate for the study in the opinion of the investigators

Where it's running

  • Seoul National University Hospital
    Seoul, Seoul, South Korea
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.